H.e.b. Pharmacy #495, Lp | |
603-a Louis Henna, Round Rock, Texas 78664 | |
(512) 828-0814 |
Name | H.e.b. Pharmacy #495, Lp |
---|---|
Organization Name | H-e-b Lp |
Location | 603-a Louis Henna, Round Rock, Texas 78664 |
Type | Community/Retail Pharmacy |
Phone | (512) 828-0814 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Cepheid announced today that it has filed an answer and counterclaims in a patent suit brought by Abaxis on June 28, 2010 in the United States District Court for the Northern District of California. In its filing, Cepheid denied Abaxis' allegations of patent infringement, asked the Court to determine it has paid all royalties due and is in full compliance with all the terms of its license, and to find that Abaxis' patents are invalid.
Affymetrix, Inc. and the National Institute of Allergy and Infectious Diseases (NIAID)-supported Pathogen Functional Genomics Resource Center (PFGRC) at the J. Craig Venter Institute (JCVI) today announced the launch of the Affymetrix FDA-ECSG custom microarray for identifying and discriminating between different strains of E. coli and Shigella.
Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have found an explanation for why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa).
More typically, these immature immune cells might help us fight cancer, but scientists have now shown cancer can commandeer the cells to help it spread.
Offering universal late pregnancy ultrasounds at 36 weeks' gestation eliminates undiagnosed breech presentation of babies, lowers the rate of emergency cesarean sections, and improves the health of mothers and babies.
› Verified 1 days ago
NPI Number | 1538400296 |
Organization Name | H-E-B, LP |
Type | Community/Retail Pharmacy |
Address | 603 Louis Henna Blvd, Round Rock, TX 78664 |
Phone Number | 512-828-0814 |
News Archive
Cepheid announced today that it has filed an answer and counterclaims in a patent suit brought by Abaxis on June 28, 2010 in the United States District Court for the Northern District of California. In its filing, Cepheid denied Abaxis' allegations of patent infringement, asked the Court to determine it has paid all royalties due and is in full compliance with all the terms of its license, and to find that Abaxis' patents are invalid.
Affymetrix, Inc. and the National Institute of Allergy and Infectious Diseases (NIAID)-supported Pathogen Functional Genomics Resource Center (PFGRC) at the J. Craig Venter Institute (JCVI) today announced the launch of the Affymetrix FDA-ECSG custom microarray for identifying and discriminating between different strains of E. coli and Shigella.
Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have found an explanation for why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa).
More typically, these immature immune cells might help us fight cancer, but scientists have now shown cancer can commandeer the cells to help it spread.
Offering universal late pregnancy ultrasounds at 36 weeks' gestation eliminates undiagnosed breech presentation of babies, lowers the rate of emergency cesarean sections, and improves the health of mothers and babies.
› Verified 1 days ago
News Archive
Cepheid announced today that it has filed an answer and counterclaims in a patent suit brought by Abaxis on June 28, 2010 in the United States District Court for the Northern District of California. In its filing, Cepheid denied Abaxis' allegations of patent infringement, asked the Court to determine it has paid all royalties due and is in full compliance with all the terms of its license, and to find that Abaxis' patents are invalid.
Affymetrix, Inc. and the National Institute of Allergy and Infectious Diseases (NIAID)-supported Pathogen Functional Genomics Resource Center (PFGRC) at the J. Craig Venter Institute (JCVI) today announced the launch of the Affymetrix FDA-ECSG custom microarray for identifying and discriminating between different strains of E. coli and Shigella.
Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have found an explanation for why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa).
More typically, these immature immune cells might help us fight cancer, but scientists have now shown cancer can commandeer the cells to help it spread.
Offering universal late pregnancy ultrasounds at 36 weeks' gestation eliminates undiagnosed breech presentation of babies, lowers the rate of emergency cesarean sections, and improves the health of mothers and babies.
› Verified 1 days ago
Blue Sky Orthotic And Prosthetics Type: Prosthetic/Orthotic Supplier Location: 3141 Eagles Nest St, Round Rock, Texas 78665 Phone: (512) 761-3646 | |
Cvs Pharmacy #00116 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2001 E Palm Valley Blvd, Round Rock, Texas 78665 Phone: (512) 244-1069 | |
Cvs Pharmacy #00928 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 800 W Old Settlers Blvd, Round Rock, Texas 78681 Phone: (512) 255-1331 | |
Cvs Pharmacy #02368 Type: Medicare Supplier Location: 7001 Wyoming Springs, Round Rock, Texas 78681 Phone: (512) 716-0757 | |
Cvs Pharmacy #06690 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 501 University Blvd, Round Rock, Texas 78665 Phone: (512) 310-8791 |